Pfizer-BioNTech
Pfizer-BioNTech apply for US authorization to use Its vaccine in adolescents : Statement
Washington/Sputnik: Pfizer and BioNTech said in a statement that they have applied to expand emergency use authorization of their vaccine for usage in adolescents between 12 and 15 years old.
"Pfizer Inc. and BioNTech SE today requested amendments to the US Emergency Use Authorization (EUA) of the Pfizer-BioNTech Vaccine (BNT162b2) to expand the use in adolescents 12 to 15 years of age," the statement said on Friday.
The EUA requests are based on the recent results of the concluded Phase 3 trial in adolescents 12 to 15 years of age with or without prior evidence of the novel coronavirus that demonstrated 100 percent efficacy and strong antibody response after vaccination with the Pfizer-BioNTech vaccine.
In the coming days, the companies plan to request similar authorization by the regulatory authorities in other countries worldwide, the statement added.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
